A more recent 2020 meta-analysis of 21 trials testing metformin found the drug had a clinically significant impact on ...

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

A 2020 meta-analysis of 21 metformin trials found the drug had a clinically significant impact on lowering BMI — particularly in folks considered to have obesity. A smaller study on metformin ...

We included double-blind RCTs of ≥6 months duration with obese subjects age ≤19 years without diabetes and without secondary or syndromic causes of obesity. Primary outcomes of interest were ...

A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with ...

At baseline, participants without undertaking any antidiabetic agents had HbA1c between 6.5% and 10%, and those taking metformin exhibited HbA1c less than 10%. Individuals with serious ...